Kentucky Women's Justice Community Overdose Innovation Network - Phase II
This study, called WJCOIN-II, is looking for women in Kentucky who are transitioning from jail to rural communities and are at risk of overdose due to opioid or stimulant use disorder. The goal is to reduce overdose risk during this high-risk time. You would be assigned to one of four groups that receive different combinations of an Overdose Prevention Intervention Package (OPIP). This package includes things like Recovery Coaching (RC) and potentially involving a support person (SPE). Researchers will measure your overdose risk at 3, 6, and 12 months after release, and whether you start treatment within one month after release. To join, you must be a woman aged 18 or older with a diagnosis of opioid and/or stimulant use disorder, have a release date within 7-60 days, and be willing to consider treatment and provide contact information for a community support person. The current recruitment status is unclear.
- Study design
- This is an interventional study with 300 planned participants. It uses a multi-level 2x2 randomized factorial design, meaning participants are randomly assigned to one of four study conditions.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after release, with measurements taken at 1, 3, 6, and 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Michele Staton, PhD · PRINCIPAL_INVESTIGATOR · University of Kentucky
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Overdose risk3, 6, and 12 months post-release
Overdose risk score based on days of opioid, stimulant, and polysubstance use
- Treatment entry1 month postrelease
Entry into any formal ASAM level of SUD treatment (e.g., outpatient, intensive outpatient, residential, inpatient, MOUD) (yes/no)